This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2018 Feb 1;36(4):432.

doi: 10.1200/JCO.2017.77.4950.

Errata

No authors listed

PMID: 29378157
PMCID: PMC6162030
DOI: 10.1200/JCO.2017.77.4950

Published Erratum

Errata

No authors listed. J Clin Oncol. 2018.

. 2018 Feb 1;36(4):432.

doi: 10.1200/JCO.2017.77.4950.

PMID: 29378157
PMCID: PMC6162030
DOI: 10.1200/JCO.2017.77.4950

No abstract available

PubMed Disclaimer

Erratum for

Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.
Demetri GD, Schöffski P, Grignani G, Blay JY, Maki RG, Van Tine BA, Alcindor T, Jones RL, D'Adamo DR, Guo M, Chawla S. Demetri GD, et al. J Clin Oncol. 2017 Oct 20;35(30):3433-3439. doi: 10.1200/JCO.2016.71.6605. Epub 2017 Aug 30. J Clin Oncol. 2017. PMID: 28854066 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations